We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$52.5B
AUM Growth
+$3.43B
Cap. Flow
-$722M
Cap. Flow %
-1.38%
Top 10 Hldgs %
14.5%
Holding
3,132
New
75
Increased
2,208
Reduced
412
Closed
54

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$69.9M
2
TMO icon
Thermo Fisher Scientific
TMO
+$67.9M
3
WFC icon
Wells Fargo
WFC
+$64.1M
4
JPM icon
JPMorgan Chase
JPM
+$63.1M
5
PFE icon
Pfizer
PFE
+$62.5M

Sector Composition

Rank Sector Weight
1 Financials 14.51%
2 Healthcare 13.47%
3 Technology 13.05%
4 Industrials 11.46%
5 Energy 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNXL
3026
DELISTED
Uni-Pixel, Inc.
UNXL
$145K ﹤0.01%
14,400
RVLT
3027
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$145K ﹤0.01%
4,230
KIOR
3028
DELISTED
KIOR, INC CLASS A COM STK
KIOR
$144K ﹤0.01%
85,338
+720
+0.9% +$1.57K
GMO
3029
DELISTED
General Moly, Inc.
GMO
$143K ﹤0.01%
106,000
NSPH
3030
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$138K ﹤0.01%
2,995
RGLS
3031
DELISTED
Regulus Therapeutics
RGLS
$134K ﹤0.01%
151
VMEM
3032
DELISTED
VIOLIN MEMORY, INC.
VMEM
$134K ﹤0.01%
+8,425
New +$181K
ISSC icon
3033
Innovative Solutions & Support
ISSC
$355M
$131K ﹤0.01%
17,900
TTGT icon
3034
TechTarget
TTGT
$269M
$131K ﹤0.01%
19,000
-40,900
-68% -$230K
FOLD
3035
DELISTED
Amicus Therapeutics
FOLD
$130K ﹤0.01%
55,200
BIOL
3036
DELISTED
Biolase, Inc.
BIOL
$130K ﹤0.01%
4
XBKS
3037
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$130K ﹤0.01%
7,410
ULTR
3038
DELISTED
ULTRAPETROL (BAHAMAS) LTD COM STK
ULTR
$127K ﹤0.01%
33,800
GMAN
3039
DELISTED
Gordmans Stores, Inc.
GMAN
$127K ﹤0.01%
16,454
+432
+3% +$4.06K
HNRG icon
3040
Hallador Energy
HNRG
$738M
$126K ﹤0.01%
15,600
-17,900
-53% -$133K
SKH
3041
DELISTED
SKILLED HEALTHCARE GROUP, INC. CLASS A COM STK
SKH
$125K ﹤0.01%
25,900
CACB
3042
DELISTED
Cascade Bancorp
CACB
$124K ﹤0.01%
23,553
+576
+3% +$3.08K
BSF
3043
DELISTED
Bear State Financial, Inc.
BSF
$123K ﹤0.01%
15,667
TLRA
3044
DELISTED
Telaria, Inc.
TLRA
$118K ﹤0.01%
20,231
+504
+3% +$3.5K
TPST icon
3045
Tempest Therapeutics
TPST
$16M
$117K ﹤0.01%
4
EVRY
3046
DELISTED
EVERYWARE GLOBAL INC COM STK (DE)
EVRY
$116K ﹤0.01%
13,900
BBGI icon
3047
Beasley Broadcasting Group
BBGI
$39.7M
$115K ﹤0.01%
655
MVNR
3048
DELISTED
MAVENIR SYS INC COM STK (DE)
MVNR
$115K ﹤0.01%
+10,300
New +$105K
LITS
3049
Lite Strategy Inc
LITS
$29.4M
$110K ﹤0.01%
685
AMSC icon
3050
American Superconductor
AMSC
$1.55B
$107K ﹤0.01%
6,500

Similar funds

Charles Schwab's Q4 2013 Portfolio in Review

As of Q4 2013, Charles Schwab held 3,132 positions worth $52.5B, up 7% from $49.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 4.1%. Charles Schwab opened 75 new positions and exited 54, leaving the 3,132-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

  • Charles Schwab's largest Q4 2013 buy was Allergan plc: 398,955 shares worth $67M.
  • Charles Schwab added most to Meta Platforms (Facebook) in Q4 2013, an estimated $94.5M increase.
  • Charles Schwab's biggest Q4 2013 reduction was Apple, cutting an estimated $69.9M.
  • Charles Schwab fully exited DELL INC in Q4 2013, selling an estimated $45.2M.
  • Charles Schwab's ten largest holdings make up 14% of its $52.5B portfolio in Q4 2013.
  • Charles Schwab opened 75 new positions and closed 54 in Q4 2013.
  • Charles Schwab's portfolio value rose 7% quarter-over-quarter to $52.5B.

Based on Charles Schwab's 13F filing for Q4 2013, filed 14 Feb 2014.